IDiyas

For the Inventor, By the Inventor

Apex, NC, United States of America

Gunnar E Jagdmann, Jr

USPTO Granted Patents = 11

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 121(Granted Patents)


Location History:

  • Richmond, VA (US) (1985)
  • Durham, NC (US) (1991)
  • Apex, NC (US) (1992 - 1996)

Company Filing History:

goldMedal8 out of 218 
 
A. H. Robins Company, Incorporated
 patents
silverMedal3 out of 1,567 
 
American Home Products Corporation
 patents

Years Active: 1985-1996

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5519037 - N-cyanoamidine derivatives as anti-influenza agents (1996-05-21),
2. 5475012 - N-cyanoamidine derivatives as anti-influenza agents (1995-12-12),
3. 5380734 - N-cyanoamidine derivatives as anti-influenza agents (1995-01-10),
4. 5273972 - [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates (1993-12-28),
5. 5244907 - Carbocyclic carboxylic acid amides and esters of azabicyclic compounds (1993-09-14),
6. 5236931 - 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine (1993-08-17),
7. 5190953 - Heterocyclic carboxylic acid amides and esters of azabicyclic compounds (1993-03-02),
8. 5137895 - 3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols (1992-08-11),
9. 5084460 - Methods of therapeutic treatment with (1992-01-28),
10. 5070095 - Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- and (1991-12-03),
11. 4547518 - Antiemetic N-(1-substituted-4,5-dihydro-1H-pyrazol-4-yl)benzamides (1985-10-15),

Title: Understanding the Innovations of Gunnar E Jagdmann, Jr.

Introduction

Gunnar E Jagdmann, Jr. is a notable inventor based in Apex, North Carolina, USA. With an impressive portfolio of 11 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-influenza agents.

Latest Patents

Among his latest innovations are the N-cyanoamidine derivatives designed as anti-influenza agents. The first patent details compounds with a specific formula that exhibits antiviral activity against Influenza A. The compounds are characterized by having the formula: ##STR1##, where X is ##STR2##, with one of R.sup.1 and R.sup.2 being H, while the other is phenylamino, and Z is --SCH.sub.3 or a pharmaceutically acceptable salt thereof. The second patent expands on this idea, incorporating various substitutions of X, such as 2-phenylethyl or 2-furanylmethyl, thus broadening the application of these anti-influenza agents.

Career Highlights

Gunnar E Jagdmann, Jr. has had a fruitful career working with prominent companies in the pharmaceutical industry. His contributions at A. H. Robins Company, Incorporated, and American Home Products Corporation have been pivotal in advancing research and development in effective medicinal solutions.

Collaborations

Throughout his career, Gunnar has collaborated with various talented individuals, notably Harry R Munson, Jr., and Kuo-Hom L Hsu. These partnerships have played a vital role in enhancing the innovation process and fostering new ideas within the pharmaceutical landscape.

Conclusion

Gunnar E Jagdmann, Jr. remains a significant figure in the world of inventions and innovations. His dedication to developing effective anti-influenza therapies showcases his commitment to enhancing public health through scientific advancements. As he continues to work within the industry, his contributions will undoubtedly influence future research and development in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…